271 related articles for article (PubMed ID: 22746999)
41. Management of medication-overuse headache.
Obermann M; Katsarava Z
Expert Rev Neurother; 2007 Sep; 7(9):1145-55. PubMed ID: 17868013
[TBL] [Abstract][Full Text] [Related]
42. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
[TBL] [Abstract][Full Text] [Related]
43. Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex.
Riederer F; Gantenbein AR; Marti M; Luechinger R; Kollias S; Sándor PS
J Neurosci; 2013 Sep; 33(39):15343-9. PubMed ID: 24068801
[TBL] [Abstract][Full Text] [Related]
44. Prevention and management of medication overuse headache.
Russell MB; Lundqvist C
Curr Opin Neurol; 2012 Jun; 25(3):290-5. PubMed ID: 22547100
[TBL] [Abstract][Full Text] [Related]
45. In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas.
Ferraro S; Grazzi L; Muffatti R; Nava S; Ghielmetti F; Bertolino N; Mandelli ML; Visintin E; Bruzzone MG; Nigri A; Epifani F; Bussone G; Chiapparini L
Headache; 2012; 52(10):1520-34. PubMed ID: 23094707
[TBL] [Abstract][Full Text] [Related]
46. Grey matter abnormalities in first-episode schizophrenia and affective psychosis.
Morgan KD; Dazzan P; Orr KG; Hutchinson G; Chitnis X; Suckling J; Lythgoe D; Pollock SJ; Rossell S; Shapleske J; Fearon P; Morgan C; David A; McGuire PK; Jones PB; Leff J; Murray RM
Br J Psychiatry Suppl; 2007 Dec; 51():s111-6. PubMed ID: 18055926
[TBL] [Abstract][Full Text] [Related]
47. Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
Teipel SJ; Bokde AL; Born C; Meindl T; Reiser M; Möller HJ; Hampel H
Brain; 2007 Jul; 130(Pt 7):1745-58. PubMed ID: 17566054
[TBL] [Abstract][Full Text] [Related]
48. Morphometric changes over the whole brain in caffeine-containing combination-analgesic-overuse headache.
Chen X; Chen Z; Dong Z; Liu M; Yu S
Mol Pain; 2018; 14():1744806918778641. PubMed ID: 29877133
[TBL] [Abstract][Full Text] [Related]
49. Reduced anterior and posterior cingulate gray matter in borderline personality disorder.
Hazlett EA; New AS; Newmark R; Haznedar MM; Lo JN; Speiser LJ; Chen AD; Mitropoulou V; Minzenberg M; Siever LJ; Buchsbaum MS
Biol Psychiatry; 2005 Oct; 58(8):614-23. PubMed ID: 15993861
[TBL] [Abstract][Full Text] [Related]
50. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study.
Yamasue H; Iwanami A; Hirayasu Y; Yamada H; Abe O; Kuroki N; Fukuda R; Tsujii K; Aoki S; Ohtomo K; Kato N; Kasai K
Psychiatry Res; 2004 Sep; 131(3):195-207. PubMed ID: 15465289
[TBL] [Abstract][Full Text] [Related]
51. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study.
Szeszko PR; Ardekani BA; Ashtari M; Malhotra AK; Robinson DG; Bilder RM; Lim KO
Arch Gen Psychiatry; 2005 Jul; 62(7):782-90. PubMed ID: 15997020
[TBL] [Abstract][Full Text] [Related]
52. Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment.
Chua SE; Deng Y; Chen EY; Law CW; Chiu CP; Cheung C; Wong JC; Lienenkaëmper N; Cheung V; Suckling J; McAlonan GM
Psychol Med; 2009 May; 39(5):793-800. PubMed ID: 18713487
[TBL] [Abstract][Full Text] [Related]
53. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
[TBL] [Abstract][Full Text] [Related]
54. Neuroanatomical differences between familial and sporadic schizophrenia and their parents: an optimized voxel-based morphometry study.
Lui S; Deng W; Huang X; Jiang L; Ouyang L; Borgwardt SJ; Ma X; Li D; Zou L; Tang H; Chen H; Li T; McGuire P; Gong Q
Psychiatry Res; 2009 Feb; 171(2):71-81. PubMed ID: 19168334
[TBL] [Abstract][Full Text] [Related]
55. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder.
Etkin A; Prater KE; Schatzberg AF; Menon V; Greicius MD
Arch Gen Psychiatry; 2009 Dec; 66(12):1361-72. PubMed ID: 19996041
[TBL] [Abstract][Full Text] [Related]
56. Brain structural changes in essential tremor: voxel-based morphometry at 3-Tesla.
Benito-León J; Alvarez-Linera J; Hernández-Tamames JA; Alonso-Navarro H; Jiménez-Jiménez FJ; Louis ED
J Neurol Sci; 2009 Dec; 287(1-2):138-42. PubMed ID: 19717167
[TBL] [Abstract][Full Text] [Related]
57. Screening and behavioral management: medication overuse headache--the complex case.
Lake AE
Headache; 2008 Jan; 48(1):26-31. PubMed ID: 18184282
[TBL] [Abstract][Full Text] [Related]
58. Regional grey matter abnormalities in juvenile myoclonic epilepsy: a voxel-based morphometry study.
Kim JH; Lee JK; Koh SB; Lee SA; Lee JM; Kim SI; Kang JK
Neuroimage; 2007 Oct; 37(4):1132-7. PubMed ID: 17689105
[TBL] [Abstract][Full Text] [Related]
59. Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity.
Schiffer B; Müller BW; Scherbaum N; Forsting M; Wiltfang J; Leygraf N; Gizewski ER
Brain; 2010 Oct; 133(10):3093-103. PubMed ID: 20647266
[TBL] [Abstract][Full Text] [Related]
60. Grey matter deficits and symptom profile in first episode schizophrenia.
Whitford TJ; Farrow TF; Gomes L; Brennan J; Harris AW; Williams LM
Psychiatry Res; 2005 Aug; 139(3):229-38. PubMed ID: 16055311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
